Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 21 Jul 2023

Immunoprecipitation methods impact the peptide repertoire in immunopeptidomics

in Cancer Immunity and Immunotherapy

Marcel Wacker
Jens Bauer
Laura Wessling
Marissa Dubbelaar
Annika Nelde
Hans-Georg Rammensee
Juliane S. Walz

Frontiers in Immunology

doi 10.3389/fimmu.2023.1219720

7,248 views
6 citations

Systematic Review

Published on 21 Jul 2023

Prognostic nutritional index as a prognostic biomarker for gastrointestinal cancer patients treated with immune checkpoint inhibitors

in Cancer Immunity and Immunotherapy

Lilong Zhang
Wangbin Ma
Zhendong Qiu
Tianrui Kuang
Kunpeng Wang
Baohong Hu
Weixing Wang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1219929

11,781 views
66 citations

Review

Published on 21 Jul 2023

Targeting reactive oxygen species and fat acid oxidation for the modulation of tumor-associated macrophages: a narrative review

in Cancer Immunity and Immunotherapy

Yujian Teng
Licheng Xu
Wenjing Li
Pengyan Liu
Linli Tian
Ming Liu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1224443

5,617 views
9 citations

Review

Published on 21 Jul 2023

Unveiling tumor immune evasion mechanisms: abnormal expression of transporters on immune cells in the tumor microenvironment

in Cancer Immunity and Immunotherapy

Lu Chen
Yuchen Wang
Qingqing Hu
Yuxi Liu
Xuchen Qi
Zhihua Tang
Haihong Hu
Nengming Lin
Su Zeng
Lushan Yu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1225948

6,213 views
8 citations

Original Research

Published on 21 Jul 2023

Lenvatinib improves anti-PD-1 therapeutic efficacy by promoting vascular normalization via the NRP-1-PDGFRβ complex in hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Jieying Yang
Zhixing Guo
Mengjia Song
Qiuzhong Pan
Jingjing Zhao
Yue Huang
Yulong Han
Dijun Ouyang
Chaopin Yang
Hao Chen

Frontiers in Immunology

doi 10.3389/fimmu.2023.1212577

6,472 views
15 citations

Clinical Trial

Published on 21 Jul 2023

Safety and efficacy of transarterial chemoembolization combined with tyrosine kinase inhibitors and camrelizumab in the treatment of patients with advanced unresectable hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Jinpeng Li
Mingxin Kong
Guangji Yu
Song Wang
Zhaozhang Shi
Huihui Han
Yanyan Lin
Jutian Shi
Jinlong Song

Frontiers in Immunology

doi 10.3389/fimmu.2023.1188308

4,440 views
13 citations

Original Research

Published on 21 Jul 2023

Modeling the tumor microenvironment of anaplastic thyroid cancer: an orthotopic tumor model in C57BL/6 mice

in Cancer Immunity and Immunotherapy

Zhen Xu
Hyo Shik Shin
Yoo Hyung Kim
Seong Yun Ha
Jae-Kyung Won
Su-jin Kim
Young Joo Park
Sareh Parangi
Sun Wook Cho
Kyu Eun Lee

Frontiers in Immunology

doi 10.3389/fimmu.2023.1187388

5,345 views
1 citation

Opinion

Published on 20 Jul 2023

Toxicity in combined therapies for tumours treatments: a lesson from BAG3 in the TME?

in Cancer Immunity and Immunotherapy

Alessandra Rosati
Liberato Marzullo
Margot De Marco
Vincenzo De Laurenzi
Maria Francesca D’Amico
Maria Caterina Turco

Frontiers in Immunology

doi 10.3389/fimmu.2023.1241543

1,726 views
1 citation

Original Research

Published on 20 Jul 2023

Inhibition of MC38 colon cancer growth by multicomponent chemoimmunotherapy with anti-IL-10R antibodies, HES-MTX nanoconjugate, depends on application of IL-12, IL-15 or IL-18 secreting dendritic cell vaccines

in Cancer Immunity and Immunotherapy

Katarzyna Węgierek-Ciura
Jagoda Mierzejewska
Agnieszka Szczygieł
Joanna Rossowska
Anna Wróblewska
Marta Świtalska
Tomasz M. Goszczyński
Bożena Szermer-Olearnik
Elżbieta Pajtasz-Piasecka

Frontiers in Immunology

doi 10.3389/fimmu.2023.1212606

5,502 views
3 citations

Editorial

Published on 20 Jul 2023

Editorial: Immune regulation and intervention in virus-related tumor development

in Cancer Immunity and Immunotherapy

Qinglin Mo
Wei Zhu
Sha Wu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1217980

1,289 views
1 citation

Editorial

Published on 20 Jul 2023

Editorial: Expert opinions and perspectives in adoptive cell therapy for cancer: 2022

in Cancer Immunity and Immunotherapy

Beatriz Martín-Antonio

Frontiers in Immunology

doi 10.3389/fimmu.2023.1257016

1,428 views

Original Research

Published on 20 Jul 2023

Comprehensive analysis and immune landscape of chemokines- and chemokine receptors-based signature in hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Ze Zhang
Mingsong Mao
Fangzhou Wang
Yao Zhang
Jihang Shi
Lei Chang
Xiaolin Wu
Zhenpeng Zhang
Ping Xu
Shichun Lu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1164669

6,036 views
3 citations

Review

Published on 20 Jul 2023

Tumor-resident memory T cells as a biomarker of the response to cancer immunotherapy

in Cancer Immunity and Immunotherapy

Isabelle Damei
Tatiana Trickovic
Fathia Mami-Chouaib
Stéphanie Corgnac

Frontiers in Immunology

doi 10.3389/fimmu.2023.1205984

13,653 views
35 citations

Original Research

Published on 19 Jul 2023

An optimized cultivation method for future in vivo application of γδ T cells

in Cancer Immunity and Immunotherapy

Anna Bold
Heike Gross
Elisabeth Holzmann
Stefan Knop
Timm Hoeres
Martin Wilhelm

Frontiers in Immunology

doi 10.3389/fimmu.2023.1185564

4,107 views
7 citations

Review

Published on 19 Jul 2023

The abscopal effect of immune-radiation therapy in recurrent and metastatic cervical cancer: a narrative review

in Cancer Immunity and Immunotherapy

Luc Ollivier
Camille Moreau Bachelard
Emmanuelle Renaud
Estelle Dhamelincourt
Francois Lucia

Frontiers in Immunology

doi 10.3389/fimmu.2023.1201675

6,967 views
6 citations

Original Research

Published on 19 Jul 2023

ChemR23 activation reprograms macrophages toward a less inflammatory phenotype and dampens carcinoma progression

in Cancer Immunity and Immunotherapy

Margot Lavy
Vanessa Gauttier
Alison Dumont
Florian Chocteau
Sophie Deshayes
Judith Fresquet
Virginie Dehame
Isabelle Girault
Charlène Trilleaud
Stéphanie Neyton

Frontiers in Immunology

doi 10.3389/fimmu.2023.1196731

6,298 views
13 citations